A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians.
T K Young and
E S Hershfield
This paper reports a case-control study to assess the protectiveeffect of BCG (bacille Calmette-Guérin) vaccination amongIndian infants in Manitoba, Canada. A record of past BCG vaccinationwas found in 49 per cent of the tuberculosis cases, comparedto 77 per cent of the controls, yielding a relative risk of0.30. Stratified analysis, controlling for age, increased therelative risk to 0.39 (95% confidence interval 0.22 - 0.69).The preventive fraction was 44 per cent. Non-differential misclassificationof exposure status could have occurred; if this was adjustedfor, the relative risk would be reduced. If only bacteriologicallyconfirmed cases were analyzed, the age-adjusted relative riskwas 0.27. The protective effect of BCG vaccination in the newbornamong Manitoba Indians is therefore at least 60 per cent. Theimplications for health policy in this population are furtherdiscussed.
This article has been cited by other articles:
M. Lauzardo and D. Ashkin Phthisiology at the Dawn of the New Century
Chest,
May 1, 2000;
117(5):
1455 - 1473.
[Abstract][Full Text][PDF]
TB among aboriginal Canadians
Can. Med. Assoc. J.,
May 1, 2000;
162(10):
1404 - 1405.
G. A. Colditz, T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
JAMA,
March 2, 1994;
271(9):
698 - 702.
[Abstract][PDF]
Use of BCG Vaccines in the Control of Tuberculosis: A Joint Statement by the ACIP and the Advisory ACIP Committee for Elimination of Tuberculosis
JAMA,
November 25, 1988;
260(20):
2983 - 2991.
[PDF]